National Biotechnology Initiative Act of 2025
Latest action (9 Apr 2025): Introduced
What this bill does
# S. 1387 — National Biotechnology Initiative Act of 2025
This bill would establish a formal "National Biotechnology Initiative" led by the President through the Executive Office of the President, aimed at advancing national security, economic competitiveness, and productivity related to biotechnology. It would create an Interagency Committee—with representatives from agencies such as Defense, Commerce, Agriculture, Energy, Health and Human Services, and others—along with a new National Biotechnology Coordination Office to oversee planning. The Office's director, appointed by the President, would coordinate federal research funding, regulatory policy, biosecurity efforts, workforce development, and international partnerships related to biotechnology. The bill also directs creation of a public website consolidating federal biotechnology information and regulatory guidance, along with periodic reports to Congress and a national biotechnology strategy.
The bill primarily affects federal agencies, directing them to coordinate biotechnology-related activities, streamline overlapping regulations, and support workforce training and research funding. It would also affect businesses and researchers working with biotechnology products by aiming to clarify and simplify regulatory pathways, and it could indirectly affect the public through efforts to improve access to plain-language information about biotechnology. The Act authorizes federal appropriations—$22 million in fiscal year 2026 rising to $35 million in 2027, then $25 million annually through 2030—to support the Office's operations, administered through the National Science Foundation.
The bill was introduced in the Senate on April 9, 2025, by Senator Todd Young with Senator Padilla as a cosponsor, and referred to the Committee on Health, Education, Labor, and Pensions. It has not yet been voted on by the committee or the full Senate, and would need to pass both chambers of Congress and be signed by the President before taking effect.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on April 9, 2025. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does S. 1387 do?
- # S. 1387 — National Biotechnology Initiative Act of 2025 This bill would establish a formal "National Biotechnology Initiative" led by the President through the Executive Office of the President, aimed at advancing national security, economic competitiveness, and productivity related to biotechnology. It would create an Interagency Committee—with representatives from agencies such as Defense, Commerce, Agriculture, Energy, Health and Human Services, and others—along with a new National Biotechnology Coordination Office to oversee planning. The Office's director, appointed by the President, would coordinate federal research funding, regulatory policy, biosecurity efforts, workforce development, and international partnerships related to biotechnology. The bill also directs creation of a public website consolidating federal biotechnology information and regulatory guidance, along with periodic reports to Congress and a national biotechnology strategy. The bill primarily affects federal agencies, directing them to coordinate biotechnology-related activities, streamline overlapping regulations, and support workforce training and research funding. It would also affect businesses and researchers working with biotechnology products by aiming to clarify and simplify regulatory pathways, and it could indirectly affect the public through efforts to improve access to plain-language information about biotechnology. The Act authorizes federal appropriations—$22 million in fiscal year 2026 rising to $35 million in 2027, then $25 million annually through 2030—to support the Office's operations, administered through the National Science Foundation. The bill was introduced in the Senate on April 9, 2025, by Senator Todd Young with Senator Padilla as a cosponsor, and referred to the Committee on Health, Education, Labor, and Pensions. It has not yet been voted on by the committee or the full Senate, and would need to pass both chambers of Congress and be signed by the President before taking effect.
- Has S. 1387 become law?
- Not yet. As of 9 Apr 2025, S. 1387 is introduced.
- Who sponsored S. 1387?
- S. 1387 was sponsored by Sen. Todd Young [R-IN] (Republican-IN), with 1 cosponsor.
- What's the latest action on S. 1387?
- Introduced (9 Apr 2025).
Related bills in Health
Expressing support for the designation of September 22, 2026, as “National Hispanic Nurses Day” and recognizing the National Association of Hispanic Nurses as the leading organization representing and advocating for Hispanic nurses.
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Expressing support for the designation of the third week of September as “Fungal Disease Awareness Week” and encouraging efforts to improve awareness, diagnosis, treatment, surveillance, and prevention of fungal diseases in the United States.
A resolution supporting the designation of October 2026 as “Substance Use & Misuse Prevention Month” to raise awareness of substance use and misuse in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.